Overview

12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Comparative trials of urokinase (UK) for 12 hours(UK-12h)or 24 hours (UK-24h) have produced similar results in acute pulmonary thromboembolism (PTE) thrombolysis. It is unclear whether the infusion time can be reduced further. The aim of this study was to investigate the efficacy and safety of weight adjusted dosage of UK-2h (20 000 IU/Kg) regime with the Uk-12h regime in selected patients with PTE in Chinese population.
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Chao Yang Hospital
Treatments:
Fibrinolytic Agents